Cameron Marlow

发表

p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape

A. Partin, D. Makarov, Sumit Isharwal, 2008, The Prostate.

Prediction of Prostate-Specific Antigen Recurrence in Men with Long-term Follow-up Postprostatectomy Using Quantitative Nuclear Morphometry

Robert W Veltri, Alan W Partin, Danil V Makarov, 2008, Cancer Epidemiology Biomarkers & Prevention.

Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis

A. Partin, J. Epstein, M. C. Miller, 2007, The Prostate.

Imaging, Diagnosis, Prognosis Pro–Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer

A. Partin, L. Sokoll, J. Epstein, 2009 .

Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana.

C. Shiff, Cameron Marlow, R. Veltri, 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo

P. V. van Diest, M. Carducci, Cameron Marlow, 2008, Molecular Cancer Therapeutics.

Pro–Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer

A. Partin, L. Sokoll, J. Epstein, 2009, Clinical Cancer Research.

Immunohistochemical Staining of Precursor Forms of Prostate-specific Antigen (proPSA) in Metastatic Prostate Cancer

A. Parwani, A. DeMarzo, Cameron Marlow, 2006, The American journal of surgical pathology.

ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.

A. Partin, L. Sokoll, J. Epstein, 2011, Urology.

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent

Robert W Veltri, Alan W Partin, Danil V Makarov, 2008, The Prostate.

DNA content in the diagnostic biopsy for benign‐adjacent and cancer‐tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme

A. Partin, J. Epstein, H. Carter, 2010, BJU international.

Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancer.

A. Partin, Cameron Marlow, R. Veltri, 2006, Urology.